President Donald J. Trump, joined by Vice President Mike Pence, listens to Gilead CEO Daniel O’Day Friday, May 1, 2020 in the Oval Office of the White House, at the announce that Gilead now has a EUA from the Food & Drug Administration (FDA) for the drug Remdesivir and to start immediate clinical trials in the battle against COVID-19. (Official White House Photo by Joyce N. Boghosian)